---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-057769"
form_type: "8-K"
ticker: "ATNM"
cik: "0001388320"
company_name: "Actinium Pharmaceuticals, Inc."
filed_at: "2021-11-09T23:59:59+00:00"
generated_at: "2026-06-28T10:34:25.754694+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Actinium shareholders re-elect two Class II directors; approve 2.75M share increase to 2019 Plan

## Summary
- Sandesh Seth and Jeffrey W. Chell re-elected as Class II directors for term expiring at 2024 annual meeting.
- Shareholders approved Second Amendment to 2019 Plan, increasing available shares by 2,750,000 to total 5,833,333.
- Marcum LLP ratified as independent auditor for FY 2021 with 12,371,473 votes for.
- Broker non-votes totaled 6,568,275 on director elections and plan amendment.
- Annual meeting had 12,755,273 shares present; no other matters were voted on.

## SEC filing metadata
- accession: 0001213900-21-057769
- form_type: 8-K
- ticker: ATNM
- cik: 0001388320
- company_name: Actinium Pharmaceuticals, Inc.
- filed_at: 2021-11-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1388320/000121390021057769/0001213900-21-057769-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1388320/000121390021057769/ea150278-8k_actiniumph.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-057769
- JSON: https://secwatch.observer/filing/0001213900-21-057769.json
- Plain text: https://secwatch.observer/filing/0001213900-21-057769.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.